Literature DB >> 31439257

Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.

Jing Lu1, Shan Pi1, Feng Hua Ma2, Shu Hui Zhao3, Hai Ming Li1, Shu Lei Cai2, Jin Wei Qiang4.   

Abstract

PURPOSE: To compare the diagnostic performance of normalized apparent diffusion coefficients (nADCs) of different references with that of ADCs at differentb factors in differentiating borderline epithelial ovarian tumors (BEOTs) from malignant epithelial ovarian tumors (MEOTs).
METHOD: This retrospective study included 53 BEOTs and 148 MEOTs. Conventional magnetic resonance and diffusion-weighted imaging withb factors of 800 and 1000s/mm2 were performed. ADC was measured three times at solid components of tumors, gluteus maximus muscle (GMM), iliopsoas muscle (IM) and urine and then averaged. ADCtumor, nADCs were then obtained. Differences and the diagnostic performance of ADCtumor and nADCs between BEOTs and MEOTs with different b factors were compared.
RESULTS: ADCtumor, nADCs regardless of b factors were significantly higher in BEOTs than MEOTs. The diagnostic performance of nADCurine regardless of b factors was significantly larger than that of nADCGMM and nADCIM. There was no significant difference in the diagnostic performance between ADCtumor and nADCurine regardless of b factors. A significantly lower ADCtumor and a larger diagnostic performance for ADCtumor was found with a b factor of 1000s/mm2 than 800 s/mm2. There were no significant differences in nADCurine of BEOTs or MEOTs or in the diagnostic performance of nADCurine with b factors between 800 and 1000s/mm2.
CONCLUSIONS: ADCtumor and nADCs were both capable of differentiating BEOTs from MEOTs. nADCurine was the best of all nADCs and was superior to ADCtumor because of its stable performance in differentiating BEOTs from MEOTs, regardless of b factors.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apparent diffusion coefficient; Borderline; Magnetic resonance imaging; Malignant; Ovarian tumor

Mesh:

Year:  2019        PMID: 31439257     DOI: 10.1016/j.ejrad.2019.06.020

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

Review 1.  Current update on malignant epithelial ovarian tumors.

Authors:  Sherif B Elsherif; Priya R Bhosale; Chandana Lall; Christine O Menias; Malak Itani; Kristina A Butler; Dhakshinamoorthy Ganeshan
Journal:  Abdom Radiol (NY)       Date:  2021-06-05

Review 2.  Serous borderline ovarian tumours: an extensive review on MR imaging features.

Authors:  Hilal Sahin; Asli Irmak Akdogan; Janette Smith; Jeries Paolo Zawaideh; Helen Addley
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

3.  Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.

Authors:  Rongping Ye; Shuping Weng; Yueming Li; Chuan Yan; Jianwei Chen; Yuemin Zhu; Liting Wen
Journal:  Korean J Radiol       Date:  2020-09-10       Impact factor: 3.500

4.  Non-contrast MRI can accurately characterize adnexal masses: a retrospective study.

Authors:  Evis Sala; Helen Addley; Hilal Sahin; Camilla Panico; Stephan Ursprung; Vittorio Simeon; Paolo Chiodini; Amy Frary; Bruno Carmo; Janette Smith; Sue Freeman; Mercedes Jimenez-Linan; Helen Bolton; Krishnayan Haldar; Joo Ern Ang; Caroline Reinhold
Journal:  Eur Radiol       Date:  2021-03-16       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.